Rino Rappuoli

Dr. Rino Rappuoli’s research focuses on vaccinology, bacterial virulence, and immunology. Dr Rappuoli was an early advocate of structure-based rational vaccine design and is known for “reverse vaccinology”--employing genomics to identify and characterize vaccine candidates. In one of his most successful applications of reverse~vaccinology, Dr. Rappuoli developed a now-licensed vaccine against meningococcus serogroup B. As an industry leader, Chief Scientist at GSK Vaccines (and previously Novartis Vaccines), and with over 600 publications, Dr. Rappuoli has been uniquely successful in retaining close ties with academia and has significantly contributed to ~fundamental research in vaccine development.